Venture Kick (Stage II)
We are delighted to share our successful second stage! 🎉
Thank you to Venture Kick for believing in us again and for their invaluable support on this exciting journey.
Lastest Posts
EVis Bioscience awarded CHF 311,000 Innosuisse grant to advance RNA therapies for rare genetic diseases
Highly competitive national selection highlights the strong scientific and clinical potential of EVis’s technology Zurich, Switzerland. EVis Bioscience AG, an ETH Zurich spin-off developing next-generation RNA delivery systems, has been selected by Innosuisse, the Swiss Innovation Agency, to receive CHF 311,000 in non-dilutive funding. This grant, awarded through a highly competitive evaluation process, will support…
Innovation Cheque
➡️Learn more about the Innovation Cheque
Venture Kick (Stage I)
🚀 EVis Bioscience has been granted by Venture Kick (stage I).The EVis team is thankful and honored to receive this fund and will do the best job for the next phase. ➡️ Learn more about Venture Kick
